Charles H. Weaver, MD

November 28, 2025

Imfinzi Plus Chemotherapy Improves Survival in Resectable Gastric and GEJ Cancer, Now FDA Approved

Charles H. Weaver, MD
November 25, 2025

Mohs Surgery – Reconstructive Surgery for Skin Cancer

Charles H. Weaver, MD
November 24, 2025

Hormone Replacement Therapy and Cancer

Charles H. Weaver, MD
November 22, 2025

Understand HPV Related Cancer & Diseases

Charles H. Weaver, MD
$New Targeted Drug Approved for Certain Adults With Relapsed or Refractory AML With an NPM1 Mutation$

November 21, 2025

New Targeted Drug Approved for Certain Adults With Relapsed or Refractory AML With an NPM1 Mutation

Charles H. Weaver, MD
November 21, 2025

New FDA Approval Expands Use of Epkinly for Follicular Lymphoma

Charles H. Weaver, MD
November 21, 2025

GLP‑1 Drugs Linked to Better 5‑Year Survival in Colon Cancer Patients With Severe Obesity

Charles H. Weaver, MD
November 21, 2025

FDA Grants Accelerated Approval to New Targeted Treatment for Some HER2-mutated Lung Cancers

Charles H. Weaver, MD
November 20, 2025

Clinical Trials and Cancer Care: Why Exploring a Clinical Trial Could Expand Your Treatment Options

Charles H. Weaver, MD
November 19, 2025

Creating the Best Support System

Charles H. Weaver, MD
November 18, 2025

Shedding Light on Vitamin D – What You Need to Know As Winter Approaches

Charles H. Weaver, MD
November 17, 2025

Imdelltra Available for Treatment of Extensive Stage Small Cell Lung Cancer

Charles H. Weaver, MD